LETTER TO THE EDITOR
|Year : 2020 | Volume
| Issue : 7 | Page : 43
COVID-19 and epilepsy
Sora Yasri1, Viroj Wiwanikit2
1 Sanitation Medical Academic Center, Bangkok, Thailand
2 Dr DY Patil University, Pune, India; Visiting Professor, Hainan Medical University, Haikou, China
|Date of Submission||04-Apr-2020|
|Date of Decision||04-Apr-2020|
|Date of Acceptance||06-Apr-2020|
|Date of Web Publication||11-Apr-2020|
Sanitation Medical Academic Center, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Yasri S, Wiwanikit V. COVID-19 and epilepsy. Ann Indian Acad Neurol 2020;23, Suppl S1:43
COVID-19 is an important emerging respiratory infection. This novel coronavirus infection can causes lung problem and might result in death. The patients with underlying disease might have poor clinical course. There are many possible concurrent medical disorders with COVID-19. Epilepsy is a common neurological disorder. There is no report on epilepsy and COVID-19. Here, the authors would like to share observations from Thailand, the second country in the timeline of COVID-19 worldwide outbreak.
At present (3th March 2020), there are 1,978 patients with COVID-19 in Thailand (there are 19 death cases). Epilepsy is comorbidity in one patient (0.05%). The patient had mild infection, and there is no seizure presentation at initial illness or during hospitalization for antiviral treatment. The patient had complete recovery. This is the first preliminary data on coincidence between epilepsy and COVID-19. Further studies are required for assessment clinical association between epilepsy and cOVID-19.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: A systematic review and meta-analysis. Arch Acad Emerg Med 2020;8:e35.
Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2019;9:1-2.